Sarepta Jumps After Feuerstein Says FDA Left Door Open For Approval
April 28, 2016 at 11:46 AM EDT
Dr. Janet Woodcock and other top FDA officials left the "door open" for accelerated approval of Sarepta's drug, eteplirsen at Monday's advisory panel.
